Lipase / প্রদাহ

Lipoprotein lipase and lipoprotein lipase activators in the treatment of inflammatory conditions

কেবল নিবন্ধিত ব্যবহারকারীরা নিবন্ধগুলি অনুবাদ করতে পারবেন

প্রবেশ করুন - নিবন্ধন করুন

FIELD OF THE INVENTION The present invention is directed to methods and compositions involving the activation of PPAR.alpha. by either the enzyme lipoprotein lipase (LPL) or by the lipolytic product monoacylglycerol (MAG). It includes topical compositions in which LPL acts on lipophylic substrates

Agent and compositions comprising the same for inhibiting lipases and phospholipases in body fluids, cells and tissues

কেবল নিবন্ধিত ব্যবহারকারীরা নিবন্ধগুলি অনুবাদ করতে পারবেন

প্রবেশ করুন - নিবন্ধন করুন

1. FIELD OF THE INVENTION The present invention relates to a protein and composition comprising the protein for inhibiting or reducing lipases and phospholipase enzymes in body fluids, cells, and tissues. The protein as described in the present invention and the composition comprising of the same

Macrophage inflammatory protein 2 (MIP-2)

কেবল নিবন্ধিত ব্যবহারকারীরা নিবন্ধগুলি অনুবাদ করতে পারবেন

প্রবেশ করুন - নিবন্ধন করুন

RELATED PUBLICATIONS The Applicants are authors or co-authors of several articles directed to the subject matter of the present invention. These articles supplement those articles listed in U.S. Pat. No. 4,603,106, which earlier articles are incorporated herein by reference. (1) [Applicant Cerami

Macrophage-derived inflammatory mediator (MIP-2)

কেবল নিবন্ধিত ব্যবহারকারীরা নিবন্ধগুলি অনুবাদ করতে পারবেন

প্রবেশ করুন - নিবন্ধন করুন

RELATED PUBLICATIONS The Applicants are authors or co-authors of several articles directed to the subject matter of the present invention. These articles supplement those articles listed in U.S. Pat. No. 4,603,106, which earlier articles are incorporated herein by reference. (1) [Applicant Cerami

Composition comprising an antibody to macrophage-derived inflammatory mediator (MIP-2)

কেবল নিবন্ধিত ব্যবহারকারীরা নিবন্ধগুলি অনুবাদ করতে পারবেন

প্রবেশ করুন - নিবন্ধন করুন

RELATED PUBLICATIONS The Applicants are authors or co-authors of several articles directed to the subject matter of the present invention. These articles supplement those articles listed in U.S. Pat. No. 4,603,106, which earlier articles are incorporated herein by reference. (1) [Applicant Cerami

Antibody to macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.)

কেবল নিবন্ধিত ব্যবহারকারীরা নিবন্ধগুলি অনুবাদ করতে পারবেন

প্রবেশ করুন - নিবন্ধন করুন

RELATED PUBLICATIONS The Applicants are authors or co-authors of several articles directed to the subject matter of the present invention. These articles are in supplementation to those articles listed in U.S. Pat. No. 4,603,106, which earlier articles are incorporated herein by reference. (1)

Macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.)

কেবল নিবন্ধিত ব্যবহারকারীরা নিবন্ধগুলি অনুবাদ করতে পারবেন

প্রবেশ করুন - নিবন্ধন করুন

RELATED PUBLICATIONS The Applicants are authors or co-authors of several articles directed to the subject matter of the present invention. These articles are in supplementation to those articles listed in U.S. Pat. No. 4,603,106, which earlier articles are incorporated herein by reference. (1)

Macrophage-derived inflammatory mediator (MIP-1 .alpha. and MIP-1 .beta.)

কেবল নিবন্ধিত ব্যবহারকারীরা নিবন্ধগুলি অনুবাদ করতে পারবেন

প্রবেশ করুন - নিবন্ধন করুন

RELATED PUBLICATIONS The Applicants are authors or co-authors of several articles directed to the subject matter of the present invention. These articles are in supplementation to those articles listed in U.S. Pat. No. 4,603,106, which earlier articles are incorporated herein by reference. (1)

Composition comprising antibody to macrophage-derived inflammatory mediator (MIP-.alpha. 1 and MIP-1.beta.)

কেবল নিবন্ধিত ব্যবহারকারীরা নিবন্ধগুলি অনুবাদ করতে পারবেন

প্রবেশ করুন - নিবন্ধন করুন

RELATED PUBLICATIONS The Applicants are authors or co-authors of several articles directed to the subject matter of the present invention. These articles are in supplementation to those articles listed in U.S. Pat. No. 4,603,106, which earlier articles are incorporated herein by reference. (1)

Macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.)

কেবল নিবন্ধিত ব্যবহারকারীরা নিবন্ধগুলি অনুবাদ করতে পারবেন

প্রবেশ করুন - নিবন্ধন করুন

RELATED PUBLICATIONS The Applicants are authors or co-authors of several articles directed to the subject matter of the present invention. These articles are in supplementation to those articles listed in U.S. Pat. No. 4,603,106, which earlier articles are incorporated herein by reference. (1)

Macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.)

কেবল নিবন্ধিত ব্যবহারকারীরা নিবন্ধগুলি অনুবাদ করতে পারবেন

প্রবেশ করুন - নিবন্ধন করুন

RELATED PUBLICATIONS The Applicants are authors or co-authors of several articles directed to the subject matter of the present invention. These articles are in supplementation to those articles listed in U.S. Pat. No. 4,603,106, which earlier articles are incorporated herein by reference. (1)

Macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.)

কেবল নিবন্ধিত ব্যবহারকারীরা নিবন্ধগুলি অনুবাদ করতে পারবেন

প্রবেশ করুন - নিবন্ধন করুন

RELATED PUBLICATIONS The Applicants are authors or co-authors of several articles directed to the subject matter of the present invention. These articles are in supplementation to those articles listed in U.S. Pat. No. 4,603,106, which earlier articles are incorporated herein by reference. (1)

Method for measuring the binding sites for macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.)

কেবল নিবন্ধিত ব্যবহারকারীরা নিবন্ধগুলি অনুবাদ করতে পারবেন

প্রবেশ করুন - নিবন্ধন করুন

RELATED PUBLICATIONS The Applicants are authors or co-authors of several articles directed to the subject matter of the present invention. These articles are in supplementation to those articles listed in U.S. Pat. No. 4,603,106, which earlier articles are incorporated herein by reference. (1)

Macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.)

কেবল নিবন্ধিত ব্যবহারকারীরা নিবন্ধগুলি অনুবাদ করতে পারবেন

প্রবেশ করুন - নিবন্ধন করুন

RELATED PUBLICATIONS The Applicants are authors or co-authors of several articles directed to the subject matter of the present invention. These articles are in supplementation to those articles listed in U.S. Pat. No. 4,603,106, which earlier articles are incorporated herein by reference. (1)

Methods for treating juvenile arthritis with ant-bile salt-stimulated lipase (BSSL) antibodies

কেবল নিবন্ধিত ব্যবহারকারীরা নিবন্ধগুলি অনুবাদ করতে পারবেন

প্রবেশ করুন - নিবন্ধন করুন

SEQUENCE LISTING This application incorporates by reference the sequence listing of record in application Ser. No. 13/262,805. TECHNICAL FIELD OF THE INVENTION The invention provides methods and pharmaceutical compositions comprising antagonists to the protein Bile Salt-Stimulated Lipase (BSSL) for

lipase/প্রদাহ

Lipoprotein lipase and lipoprotein lipase activators in the treatment of inflammatory conditions

Agent and compositions comprising the same for inhibiting lipases and phospholipases in body fluids, cells and tissues

Macrophage inflammatory protein 2 (MIP-2)

Macrophage-derived inflammatory mediator (MIP-2)

Composition comprising an antibody to macrophage-derived inflammatory mediator (MIP-2)

Antibody to macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.)

Macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.)

Macrophage-derived inflammatory mediator (MIP-1 .alpha. and MIP-1 .beta.)

Composition comprising antibody to macrophage-derived inflammatory mediator (MIP-.alpha. 1 and MIP-1.beta.)

Macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.)

Macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.)

Macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.)

Method for measuring the binding sites for macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.)

Macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.)

Methods for treating juvenile arthritis with ant-bile salt-stimulated lipase (BSSL) antibodies

বিজ্ঞানের দ্বারা সমর্থিত সবচেয়ে সম্পূর্ণ completeষধি ভেষজ ডেটাবেস